Full text is available at the source.
Abstract
No disease-modifying osteoarthritis drugs have successfully passed clinical trials due to insufficient cartilage penetration.
- Osteoarthritis is a prevalent joint disease with no approved therapies that modify its progression.
- Targeting the extracellular matrix is crucial for improving drug delivery to cartilage.
- Cartilage-targeting drug delivery systems may enhance penetration by utilizing their physicochemical properties.
- Positively charged biomaterials can interact with the negatively charged components of the cartilage matrix.
- Cationic nanocarriers could facilitate both passive penetration and prolonged retention in cartilage.
- Active targeting strategies may improve delivery by using specific antibodies or peptides that bind to cartilage components.
Simplified